Abstract
Cerebral reperfusion injury is the major complication of mechanical thrombectomy (MT) for acute ischemic stroke (AIS). Contrast extravasation (CE) and intracranial hemorrhage (ICH) are the key radiographical features of cerebral reperfusion injury. The aim of this study was to investigate CE and ICH after MT in the anterior and posterior circulation, and their effect on functional outcome. This is a retrospective study of all consecutive patients who were treated with MT for AIS at University of California Irvine Medical Center between January 1, 2014, and December 31, 2017. Patient characteristics, clinical features, procedural variables, contrast extravasation, ICH, and outcomes after MT were analyzed. A total of 131 patients with anterior circulation (AC) stroke and 25 patients with posterior circulation (PC) stroke underwent MT during the study period. There was no statistically significant difference in admission NIHSS score, blood pressure, rate of receiving intravenous tPA, procedural variables, contrast extravasation, and symptomatic ICH between the 2 groups. Patients with PC stroke had a similar rate of favorable outcome (mRS 0–2) but significantly higher mortality (40.0% vs. 10.7%, p < 0.01) than patients with AC stroke. Multivariate regression analysis identified initial NIHSS score (OR 1.1, CI 1.0–1.2, p = 0.01), number of passes with stent retriever (OR 2.1, CI 1.3–3.6, p < 0.01), and PC stroke (OR 9.3, CI 2.5–35.1, p < 0.01) as independent risk factors for death. There was no significant difference in functional outcomes between patients with and without evidence of cerebral reperfusion injury after MT. We demonstrated that AC and PC stroke had similar rates of cerebral reperfusion injury and favorable outcome after MT. Cerebral reperfusion injury is not a significant independent risk factor for poor functional outcome.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
In 2015, 5 randomized controlled trials (RCTs) demonstrated the safety and efficacy of mechanical thrombectomy (MT) for patients with acute ischemic stroke (AIS) from large vessel occlusion (LVO) within 6–12 h of symptom onset [1,2,3,4,5]. In early 2018, 2 additional RCTs showed eloquent benefit of MT in select patients within 16 to 24 h of last known well [6, 7]. Of note, all of these RCTs were performed in patients with AIS in the anterior circulation (AC). Despite empirical evidence of potential benefit of MT for AIS in the posterior circulation (PC) [8,9,10,11,12,13,14,15,16,17,18], two recent clinical trials failed to prove the superiority of MT over standard medical therapy partly due to slow enrollment, small sample size, and inclusion of patients with minor deficit [19, 20].
Cerebral reperfusion injury is the major complication of MT. Contrast extravasation (CE) and intracranial hemorrhage (ICH) are the key radiographical features of cerebral reperfusion injury after MT [21,22,23,24]. In the setting of early ischemic change, the use of intravenous thrombolytic agent, mechanical endovascular thrombectomy device or large dose of contrast, and reperfusion may all potentially cause or worsen the blood–brain barrier (BBB) breakdown and cerebral reperfusion injury [23,24,25,26]. Both CE and ICH appear hyperdense on non-contrast CT scan. There is no threshold of Hounsfield units that can be reliably used to differentiate between blood and contrast. The iodinated contrast agents are generally washed out within 24 h [21, 22]. Therefore, a repeat CT scan within 24–36 h after MT is a useful tool in determining whether an initial CT hyperdense lesion represents CE or ICH. Persistent or new hyperdense lesion at 24–36-h follow-up CT is defined as ICH, whereas complete resolution comprises CE [22,23,24].
The aim of this study was to investigate CE and ICH after MT for PC and AC strokes and to examine if cerebral reperfusion injury affects outcome.
Method and Materials
Study Design
This retrospective study was approved by the Institutional Review Board at University of California, Irvine. The following clinical and radiographic information was collected from the electronic medical record and the Stroke Center’s American Heart Association (AHA) Get with the Guidelines (GWTG)-Stroke database: age, gender, race, past medical history, social or family history, the highest blood pressure (BP) levels within 24 h of admission, National Institutes of Health Stroke Scale (NIHSS) score before and after MT, noninvasive imaging or catheter angiography findings, the use of intravenous (iv) tPA, door to needle time (DNT), door to groin puncture time (DPT), procedural duration, number of passes, hyperdense lesion on CT scans, laboratory test results, and modified Rankin Scale (mRS) score at hospital discharge.
We evaluated whether there is difference in CE and ICH after MT between PC and AC stroke. The association between post-MT hyperdense lesions and functional outcomes was also examined.
Patients
All consecutive patients who underwent emergent MT for AIS in the anterior or posterior circulation at University of California Irvine Comprehensive Stroke Center between January 1, 2014, and December 31, 2017, were included. Patients were excluded if they had neither an immediate post-MT CT scan nor a 24–36-h follow-up CT or MRI. Patients were also excluded if there were AIS in both anterior and posterior circulations. The study flowchart is shown in Fig. 1.
Protocol for MT
Our criteria for emergency MT were as follows: (1) patients presented within 6 h of symptom onset or wake up stroke; (2) NIHSS ≥ 6 and no evidence of hemorrhage on initial non-contrast CT scan; (3) no significant improvement after administration of intravenous tPA within 4.5 h of symptom onset; (4) evidence of large vessel occlusion in the anterior or posterior circulation on CTA; (5) ischemic penumbra ≥ one-third of the MCA territory on CT perfusion if patients presented with AIS in the anterior circulation 6–24 h of symptom onset or last known well. For PC stroke, MT was performed at the discretion of stroke and neuro-interventional team.
All MT procedures were performed under general anesthesia and using a stent retriever (Solitaire FR or Trevo), a direct contact aspiration device (Penumbra, Alameda, CA, USA), or both. After MT, the recanalization status was assessed using the Thrombolysis in Cerebral Infarction (TICI) scale [11]. Successful recanalization was defined as TICI 2 and TICI 3. Systolic BP was maintained at < 140 post-MT to minimize risk of reperfusion injury.
Evaluation of CE and ICH
Non-contrast CT scans were performed immediately and 24–36 h after MT in study patients. CE was defined as hyperdense lesion on the immediate post-MT CT but not on the 24–36-h follow-up scans. Persistent or new hyperdense lesion on 24–36-h follow-up CT was classified as ICH. In patients with follow-up MRI study, ICH was determined using susceptibility-weighted imaging (SWI). ICH includes intracerebral hemorrhage, subarachnoid hemorrhage (SAH), or subdural hemorrhage (SDH). Symptomatic ICH (sICH) was defined as evidence of ICH on CT scan and a neurologic deterioration with an increase in NIHSS score by more than 4 points [8]. Asymptomatic ICH (aICH) was defined as evidence of ICH on CT scan without significant neurologic deterioration. The representative images of the CE and ICH are shown in Fig. 2.
Statistical Analysis
Continuous variables were described by mean ± standard deviation (SD) or median with interquartile range (IQR) based on the results of normality testing. Categorical variables were expressed by counts with percentages. The Student t test was used to analyze the difference in continuous variables between groups. The chi-square test or Fisher’s exact test was used in univariate analyses for categorical variables. Multivariate analysis was performed using multiple logistic regression analysis to evaluate factors that might predict functional outcome. All statistical analyses were done using SPSS version 23.0 (SPSS Inc., Chicago, IL, USA), and a p value less than 0.05 was considered statistically significant.
Results
Posterior vs Anterior Circulation Stroke
During the study period, a total of 198 patients underwent endovascular procedures for AIS from large vessel occlusion (Fig. 1). The following patients were excluded from the study: (1) patients received only intra-arterial tPA, stenting, or angioplasty (n = 14); (2) patients had stroke in both anterior and posterior circulation (n = 3); (3) patients had no documented outcome data (n = 6); and (4) patients had no CT scan within 6 h post-MT (n = 19).
Thus, 156 patients were included in the final analysis. Their baseline demographics and comorbidities are shown in Table 1. The mean ages were (70.1 ± 15.3). Of the 156 patients, 69 (44.2%) were males. There were 107 (68.6%) White/Hispanic, 36 (23.1%) Asian, 2 (1.3%) African American, 1 (0.6%) Native American/Pacific Islander, and 10 (6.4%) other ethnic groups. In total, 131 (84%) patients had AC stroke and 25 (16%) had PC stroke. The PC group had significantly higher rate of family history of stroke or TIA (36.0% vs 13.0%, p = 0.01) while the AC group had higher rates of atrial fibrillation/flutter (36.6% vs 12.0%, p = 0.02) and hyperlipidemia (42% vs. 20%, p = 0.04).
The clinical characteristics, procedural data, radiographical findings of cerebral brain injury, and functional outcome in patients with PC vs. AC stroke are shown in Table 2. There was no statistically significant difference between the 2 groups in admission NIHSS score, systolic BP, rate of receiving iv tPA, onset to puncture time, procedure time, passes, and recanalization rate. There was also no significant difference in the rates of hyperdense lesion on post-MT CT scan, contrast extravasation, or sICH. Both groups had a similar rate of favorable functional outcome (mRS 0–2) at 90 days (26.7% vs 20%, p = 0.1). However, PC stroke had a significantly higher mortality rate than the AC stroke (40.0% vs. 10.7%, p < 0.01).
The distribution of discharge modified Rankin Scale (mRS) is shown in Fig. 3. Multivariate regression analysis identified that the independent risk factors for death are initial NIHSS score (OR 1.1, CI 1.0–1.2, p = 0.01), number of passes with stent retriever (OR 2.1, CI 1.3–3.6, p < 0.01), and PC stroke (OR 9.3, CI 2.5–35.1, p < 0.01) (Table 3).
Post-MT Hyperdense Lesion on CT Scan and Outcome
To investigate the possible effect of cerebral reperfusion injury on functional outcome, patients were divided into hyperdensity (HD) vs. no-hyperdensity (no-HD) group based on CT scan findings (Fig. 1). Among the 135 eligible patients, 60 had HD (44.4%) and 75 had no-HD on initial post-MT CT scan. Repeat CT scan within 24–36 h showed resolution of HD in 35 patients (CE group) and persistent HD in 25 patients (ICH group). There was new hyperdense lesion (ICH) in 14 patients who had no HD on initial CT scan, resulting in a total of 39 patients with ICH. Of the 39 patients with ICH, 8 were sICH (5.9%). There was no difference in sICH between PC and AC stroke (8% vs 4.6%) (Table 2). In one patient with basilar artery occlusion, the use of carotid angioplasty balloon caused dissection of atherosclerotic distal vertebral artery and SAH with intraventricular extension. The patient had extensive brainstem and bilateral occipital lobe infarcts likely due to basilar artery reocclusion.
As shown in Table 4, there was no significant difference between the HD and no-HD group in demographics, past medical history, social history of drug, alcohol, or tobacco use, as well as family history of stroke or TIA. There was also no significant difference in admission NIHSS score, SBP, procedural variables, and functional outcomes between the two groups (Table 5). There was a trend of higher rates of receiving iv tPA and favorable functional outcome in the no-HD group (Table 5). The rate of sICH was relatively low in both PC and AC (8% vs 4.6%). Radiographical evidence of cerebral reperfusion injury was not independently associated with poor outcome.
In subgroup analysis, patients with contrast extravasation had a significantly higher rate of cardiac comorbidities compared to patients with ICH (51.4% and 23.1%, p = 0.016). The patients with sICH had a higher rate of diabetes than patients with aICH (75.0% vs. 30.3%, p = 0.015).
Discussion
In this single center retrospective study, we demonstrated comparable rate of cerebral reperfusion injury and favorable outcome after MT in PC and AC. Patients with PC stroke had a higher rate of family history of stroke or TIA and mortality. In contrast, hyperlipidemia and atrial fibrillation were more common in patients with AC stroke. There was no statistically significant difference in hyperdense lesion, CE, ICH, and sICH after MT between PC and AC group. In multivariate regression analysis, PC stroke, initial NIHSS score, and number of passes were associated with higher mortality rate. Of note, there was no significant difference in functional outcome between the patients with and without reperfusion injury after MT. Cerebral reperfusion injury was therefore not a significant independent risk factor for mortality after MT.
Previous studies reported that prolonged procedure time increases periprocedural complications and is associated with increased rate of sICH [14, 27]. Raoult et al. found that a short onset to puncture time was associated with better outcomes [28]. Our study showed no correlation between procedural time and ICH or outcome, likely due to difference in sample size and patient selection. Both maximum blood pressure and large variations have also been shown to worsen outcome [29,30,31]. In our current study, there was no difference in initial SBP between the 2 groups and post-MT systolic BP was maintained at less than 140. Therefore, BP variation was unlikely the cause of higher mortality in patients with PC stroke. Of note, 85% of our PC stroke patients had acute basilar artery occlusion. This may be possible explanation for higher mortality rate in PC stroke as previous reported [15]. Other possible explanation can be re-occlusion of basilar artery or inclusion of patients with large pontine infarct [32], resulting in futile recanalization and possible higher rate of withdrawal of life support [15, 32]. The small sample size in the PC may be another confounding factor. Large vessel re-occlusion and futile recanalization after MT may be the next frontiers in translational stroke research.
Our data also demonstrated that there was no difference in the rate of good functional outcome (mRS 0–2) at hospital discharge between patients with and without hyperdense lesion on CT scan within 6 h of MT. Procedural variables such as onset to puncture time, procedural time, recanalization rate, and rate of receiving iv tPA were not significant predictors of development of hyperdense lesion. Our rate of hyperdense lesion (44.4%) is comparable to what were reported previously (30% and 55%) [23, 25]. Our rate of sICH (8%) in the PC stroke is also similar to what were reported in the 2 recently published RCTs (8% and 4.5%) [19, 20]. Since there was no difference in rate of hyperdense lesion, CE, or sICH between PC and AC group, indicating that cerebral reperfusion injury is not related to higher mortality rate in patients with PC stroke.
Of note, in subgroup analysis, we demonstrate that patients with CE had a significantly higher rate of cardiac comorbidities whereas the patients with sICH had a higher rate of diabetes. Pro-inflammatory cytokines and angiotensin II increases in heart failure were shown to downregulate the endothelial tight junctions of the blood–brain barrier, and this permeability increase has been measured with dynamic contrast-enhanced MRI [33]. Heart failure appeared to increase the risk of mild cerebral reperfusion injury (CE without ICH). In contrast, increased glucose levels were reported to increase cytotoxic edema and the risk for hemorrhagic transformation due to increase thrombotic and inflammatory response [34,35,36,37]. One study also reported the synergistic effect of high glucose and low BP on the risk for ICH [38]. Currently, it is unclear whether long standing diabetes, peri-procedural hyperglycemia, or both are responsible for increased risk of severe cerebral reperfusion injury.
The COMPASS trial assessed the efficacy of aspiration as first pass (n = 134) vs. stent retriever as first line (n = 136) [39]. It demonstrated no significant difference in outcome (52% vs. 50%) or intracranial hemorrhage (36 vs. 34%) between the 2 groups. We did not investigate the correlation between different thrombectomy device or combination and outcome. Instead, we examined the potential effect of the numbers of passes and procedure time on outcome and reperfusion injury. We found no significant correlation between the numbers of passes or procedure time and reperfusion injury after MT. However, multivariate regression analysis identified the number of passes as independent risk factor for death.
The major limitation of our study is the small sample size in the PC stroke group. The other limitation is that we do not have a dual energy CT, which was shown to improve accuracy in differentiating ICH from CE [22, 40].
Albeit not entirely accurate, regular CT is less resource-consuming and sensitive for the detection of CE and ICH [21, 24, 41,42,43,44]. Contrast agent was shown to be reabsorbed within 24 h and the persistence of hyperdensities after 19 to 24 h strongly favors ICH (specificity 100% and sensitivity 62.5%) [21]. MT induces abrupt reperfusion and increases the risk of BBB breakdown and secondary brain injury, predisposing patients to CE and ICH [41,42,43,44]. Regular CT is a very reliable tool for the evaluation of clinically relevant reperfusion injuries after MT.
Conclusion
AC and PC stroke have similar rate of cerebral reperfusion injury and favorable outcome after MT. Cerebral reperfusion injury is not a significant independent risk factor for poor functional outcome.
Data Availability
The data that support the findings of this study are available on request from the corresponding author.
Change history
17 February 2022
A Correction to this paper has been published: https://doi.org/10.1007/s12975-022-00989-7
References
Berkhemer OA, Fransen PS, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke [published correction appears in N Engl J Med. 2015 Jan 22;372(4):394]. N Engl J Med. 2015;372(1):11–20. https://doi.org/10.1056/NEJMoa1411587.
Campbell BC, Mitchell PJ, Kleinig TJ, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015;372:1009–18. https://doi.org/10.1056/NEJMoa1414792.
Goyal M, Demchuk AM, Menon BK, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372:1019–30. https://doi.org/10.1056/NEJMoa1414905.
Saver JL, Goyal M, Bonafe A, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med. 2015;372:2285–95. https://doi.org/10.1056/NEJMoa1415061.
Jovin TG, Chamorro A, Cobo E, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015;372:2296–306.
Nogueira RG, Jadhav AP, Haussen DC, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med. 2018;378:11–21. https://doi.org/10.1056/NEJMoa1503780.
Albers GW, Marks MP, Kemp S, et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med. 2018;378:708–18. https://doi.org/10.1056/NEJMoa1713973.
Mayer TE, Hamann GF, Brueckmann HJ. Treatment of basilar artery embolism with a mechanical extraction device: necessity of flow reversal. Stroke. 2002;33:2232–5. https://doi.org/10.1161/01.str.0000024524.71680.c6.
Yu W, Binder D, Foster-Barber A, Malek R, Smith WS, Higashida RT. Endovascular embolectomy of acute basilar artery occlusion. Neurology. 2003;61:1421–3. https://doi.org/10.1212/wnl.61.10.1421.
Singer OC, Berkefeld J, Nolte CH, et al. Mechanical recanalization in basilar artery occlusion: the ENDOSTROKE study. Ann Neurol. 2015;77:415–24. https://doi.org/10.1002/ana.24336.
Mokin M, Sonig A, Sivakanthan S, et al. Clinical and procedural predictors of outcomes from the endovascular treatment of posterior circulation strokes. Stroke. 2016;47:782–8. https://doi.org/10.1161/strokeaha.115.011598.
Alonso de Leciñana M, Kawiorski MM, Ximénez-Carrillo Á, et al. Mechanical thrombectomy for basilar artery thrombosis: a comparison of outcomes with anterior circulation occlusions. J Neurointerv Surg. 2017;9:1173–8. https://doi.org/10.1136/neurintsurg-2016-012797.
Gory B, Mazighi M, Labreuche J, et al. Predictors for mortality after mechanical thrombectomy of acute basilar artery occlusion. Cerebrovasc Dis. 2018;45(1–2):61–7. https://doi.org/10.1159/000486690.
Alawieh A, Vargas J, Turner RD, et al. Equivalent favorable outcomes possible after thrombectomy for posterior circulation large vessel occlusion compared with the anterior circulation: the MUSC experience. J Neurointerv Surg. 2018;10:735–40. https://doi.org/10.1136/neurintsurg-2017-013420.
Meinel TR, Kaesmacher J, Chaloulos-Iakovidis P, et al. Mechanical thrombectomy for basilar artery occlusion: efficacy, outcomes, and futile recanalization in comparison with the anterior circulation. J Neurointerv Surg. 2019;11(12):1174–80.
Weber R, Minnerup J, Nordmeyer H, Eyding J, Krogias C, Hadisurya J, Berger K, REVASK investigators. Thrombectomy in posterior circulation stroke: differences in procedures and outcome compared to anterior circulation stroke in the prospective multicentre REVASK registry. Eur J Neurol. 2019;26(2):299–305.
Kwak HS, Park JS. Mechanical thrombectomy in basilar artery occlusion: clinical outcomes related to posterior circulation collateral score. Stroke. 2020;51(7):2045–50.
Yoon W, Baek BH, Lee YY, Kim SK, Kim JT, Park MS. Association of pretreatment pontine infarction with extremely poor outcome after endovascular thrombectomy in acute basilar artery occlusion. J Neurointerv Surg. 2021;13(2):136–140. https://doi.org/10.1136/neurintsurg-2020-015930.
Liu X, et al. Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial. Lancet Neurol. 2020;19:115–22. https://doi.org/10.1016/s1474-4422(19)30395-3.
Langezaal LCM, van der Hoeven EJRJ, Mont’Alverne FJA, et al. Endovascular therapy for stroke due to basilar-artery occlusion. N Engl J Med. 2021;384(20):1910–20. https://doi.org/10.1056/NEJMoa2030297.
Dekeyzer S, Nikoubashman O, Lutin B, et al. Distinction between contrast staining and hemorrhage after endovascular stroke treatment: one CT is not enough. J Neurointerv Surg. 2017. https://doi.org/10.1136/neurintsurg-2016-012290.
Tijssen MP, Hofman PA, Stadler AA, et al. The role of dual energy CT in differentiating between brain haemorrhage and contrast medium after mechanical revascularisation in acute ischaemic stroke. Eur Radiol. 2014;24(4):834–40. https://doi.org/10.1007/s00330-013-3073-x.
Payabvash S, Qureshi MH, Khan SM, et al. Differentiating intraparenchymal hemorrhage from contrast extravasation on post-procedural noncontrast CT scan in acute ischemic stroke patients undergoing endovascular treatment. Neuroradiology. 2014. https://doi.org/10.1007/s00234-014-1381-8.
Lummel N, Schulte-Altedorneburg G, Bernau C, et al. Hyperattenuated intracerebral lesions after mechanical recanalization in acute stroke. Am J Neuroradiol. 2014;35(2):345–51. https://doi.org/10.3174/ajnr.A3656.
Parrilla G, García-Villalba B, Espinosa de Rueda M, et al. Hemorrhage/contrast staining areas after mechanical intra-arterial thrombectomy in acute ischemic stroke: imaging findings and clinical significance. AJNR Am J Neuroradiol. 2012;33:1791–6. https://doi.org/10.3174/ajnr.A3044.
Yu W, Jiang WJ. A simple imaging guide for endovascular thrombectomy in acute ischemic stroke: from time window to perfusion mismatch and beyond. Front Neurol. 2019;10:502. Published 2019 May 24. https://doi.org/10.3389/fneur.2019.00502.
Spiotta AM, Vargas J, Turner R, Chaudry MI, Battenhouse H, Turk AS. The golden hour of stroke intervention: effect of thrombectomy procedural time in acute ischemic stroke on outcome. J Neurointerv Surg. 2014;6:511–6. https://doi.org/10.1136/neurintsurg-2013-010726.
Raoult H, et al. Prognostic factors for outcomes after mechanical thrombectomy with solitaire stent. J Neuroradiol. 2013;40:252–9. https://doi.org/10.1016/j.neurad.2013.04.001.
Maïer B, Gory B, Taylor G, et al. Mortality and disability according to baseline blood pressure in acute ischemic stroke patients treated by thrombectomy: a collaborative pooled analysis. J Am Heart Assoc. 2017;6. https://doi.org/10.1161/jaha.117.006484.
Goyal N, Tsivgoulis G, Iftikhar S, et al. Admission systolic blood pressure and outcomes in large vessel occlusion strokes treated with endovascular treatment. J Neurointerv Surg. 2017;9:451–4. https://doi.org/10.1136/neurintsurg-2016-012386.
Goyal N, Tsivgoulis G, Pandhi A, et al. Blood pressure levels post mechanical thrombectomy and outcomes in large vessel occlusion strokes. Neurology. 2017;2017(89):540–7. https://doi.org/10.1212/WNL.0000000000004184.
Yoon W, Baek BH, Lee YY, Kim SK, Kim JT, Park MS. Association of pretreatment pontine infarction with extremely poor outcome after endovascular thrombectomy in acute basilar artery occlusion. J Neurointerv Surg. 2021;13(2):136–40. https://doi.org/10.1136/neurintsurg-2020-015930.
Bevers MB, Vaishnav NH, Pham L, Battey TW, Kimberly WT. Hyperglycemia is associated with more severe cytotoxic injury after stroke. J Cereb Blood Flow Metab. 2017;37(7):2577–83. https://doi.org/10.1177/0271678X16671730.
Desilles JP, Syvannarath V, Ollivier V, et al. Exacerbation of thromboinflammation by hyperglycemia precipitates cerebral infarct growth and hemorrhagic transformation. Stroke. 2017;48:1932–40. https://doi.org/10.1161/strokeaha.117.017080.
Chamorro Á, Brown S, Amaro S, et al. Glucose modifies the effect of endovascular thrombectomy in patients with acute stroke. Stroke. 2019;50:690–6. https://doi.org/10.1161/strokeaha.118.023769.
Zhu F, Labreuche J, Haussen DC, et al. Hemorrhagic transformation after thrombectomy for tandem occlusions. Stroke. 2019;2019(50):516–9. https://doi.org/10.1161/strokeaha.118.023689.
Sun C, Wu C, Zhao W, et al. Glycosylated hemoglobin A1c predicts intracerebral hemorrhage with acute ischemic stroke post-mechanical thrombectomy. J Stroke Cerebrovasc Dis. 2020;29(9):105008. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105008.
Laredo C, et al. Elevated glucose is associated with hemorrhagic transformation after mechanical thrombectomy in acute ischemic stroke patients with severe pretreatment hypoperfusion. Sci Rep. 2020;10:10588. https://doi.org/10.1038/s41598-020-67448-x.
Turk AS 3rd, Siddiqui A, Fifi JT, et al. Aspiration thrombectomy versus stent retriever thrombectomy as first-line approach for large vessel occlusion (COMPASS): a multicentre, randomised, open label, blinded outcome, non-inferiority trial. Lancet. 2019;393(10175):998–1008. https://doi.org/10.1016/S0140-6736(19)30297-1.
Liu K, Jiang L, Ruan J, et al. The role of dual energy CT in evaluating hemorrhagic complications at different stages after thrombectomy. Front Neurol. 2020;11:583411. Published 2020 Oct 7. https://doi.org/10.3389/fneur.2020.583411.
Wildenhain SL, Jungreis CA, Barr J, Mathis J, Wechsler L, Horton JA. CT after intracranial intraarterial thrombolysis for acute stroke. AJNR Am J Neuroradiol. 1994;15:487–92.
Khatri R, McKinney AM, Swenson B, Janardhan V. Blood-brain barrier, reperfusion injury, and hemorrhagic transformation in acute ischemic stroke. Neurology. 2012;79(13 Suppl 1):S52–7. https://doi.org/10.1212/WNL.0b013e3182697e70.
Yu W, Liu L. Therapeutic window beyond cerebral ischemic reperfusion injury. In: Jiang W, Yu W, Qu Y, Shi Z, Luo B, Zhang J, editors. Cerebral ischemic reperfusion injuries (CIRI). Springer Series in Translational Stroke. Cham: Research. Springer Nature; 2018. p. 245–59.
Gauberti M, Lapergue B, Martinez de Lizarrondo S, et al. Ischemia-reperfusion injury after endovascular thrombectomy for ischemic stroke. Stroke. 2018;49(12):3071–4. https://doi.org/10.1161/STROKEAHA.118.022015.
Author information
Authors and Affiliations
Contributions
MB: study design, data acquisition and analysis, manuscript draft and revision. SS, KG, LL, MS, LA, JS: data interpretation and intellectual discussion. DS: data acquisition and analysis. WY: study design, data interpretation, manuscript editing and final revision.
Corresponding author
Ethics declarations
Ethics Approval
This study was approved by the Institutional Review Board (IRB) at University of California Irvine. Informed consents were waived as part of the IRB approval.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Bower, M.M., Suzuki, S., Golshani, K. et al. Comparative Studies of Cerebral Reperfusion Injury in the Posterior and Anterior Circulations After Mechanical Thrombectomy. Transl. Stroke Res. 13, 556–564 (2022). https://doi.org/10.1007/s12975-021-00977-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12975-021-00977-3